je.st
news
MannKind's Afrezza Remains in Sanofi's Plans, RBC Says
2014-11-22 19:25:26| Biotech - Topix.net
Yesterday, Sanofi hosted a seminar on new medicines in Cambridge, Mass., and RBC's Adnan Butt and team note that MannKind's inhaled insulin Afrezza "featured prominently enough." They summarize the highlights of the presentation: MannKind's partner reiterated prior guidance that a commercial launch is planned for 1Q:15.
Tags: plans
says
remains
rbc
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||